TIAA CREF Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $14.3M | Buy |
129,970
+16,827
| +15% | +$1.85M | 0.01% | 862 |
|
2018
Q4 | $11.1M | Buy |
113,143
+3,776
| +3% | +$370K | 0.01% | 905 |
|
2018
Q3 | $13.5M | Sell |
109,367
-5,222
| -5% | -$645K | 0.01% | 949 |
|
2018
Q2 | $11.4M | Sell |
114,589
-4,772
| -4% | -$474K | 0.01% | 1084 |
|
2018
Q1 | $10.5M | Sell |
119,361
-6,771
| -5% | -$598K | 0.01% | 1090 |
|
2017
Q4 | $12.4M | Sell |
126,132
-9,781
| -7% | -$965K | 0.01% | 1017 |
|
2017
Q3 | $13.1M | Sell |
135,913
-32,762
| -19% | -$3.15M | 0.01% | 989 |
|
2017
Q2 | $15.9M | Buy |
168,675
+22,363
| +15% | +$2.11M | 0.01% | 866 |
|
2017
Q1 | $11.9M | Sell |
146,312
-90,907
| -38% | -$7.42M | 0.01% | 1008 |
|
2016
Q4 | $20.1M | Sell |
237,219
-11,944
| -5% | -$1.01M | 0.02% | 748 |
|
2016
Q3 | $18.6K | Buy |
249,163
+10,469
| +4% | +$780 | 0.01% | 810 |
|
2016
Q2 | $18.1M | Sell |
238,694
-14,991
| -6% | -$1.14M | 0.01% | 766 |
|
2016
Q1 | $17.6M | Sell |
253,685
-37,988
| -13% | -$2.63M | 0.01% | 795 |
|
2015
Q4 | $17.6M | Sell |
291,673
-17,391
| -6% | -$1.05M | 0.01% | 807 |
|
2015
Q3 | $16.7M | Sell |
309,064
-17,672
| -5% | -$956K | 0.01% | 803 |
|
2015
Q2 | $19M | Buy |
326,736
+114
| +0% | +$6.62K | 0.01% | 805 |
|
2015
Q1 | $19.7M | Sell |
326,622
-2,408
| -0.7% | -$145K | 0.01% | 787 |
|
2014
Q4 | $17.5M | Sell |
329,030
-16,014
| -5% | -$853K | 0.01% | 827 |
|
2014
Q3 | $15.4M | Sell |
345,044
-9,344
| -3% | -$418K | 0.01% | 861 |
|
2014
Q2 | $14.9M | Buy |
354,388
+3,868
| +1% | +$163K | 0.01% | 915 |
|
2014
Q1 | $15.4M | Sell |
350,520
-4,650
| -1% | -$205K | 0.01% | 891 |
|
2013
Q4 | $17.4M | Buy |
355,170
+19,652
| +6% | +$964K | 0.01% | 850 |
|
2013
Q3 | $13.8M | Buy |
335,518
+3,006
| +0.9% | +$124K | 0.01% | 913 |
|
2013
Q2 | $11.7M | Buy |
+332,512
| New | +$11.7M | 0.01% | 954 |
|